Clinical Scorecard: Case Study: Expanding Applications of STAR-Inspired Single-Fraction Cardiac Radioablation for Metastatic Ewing Sarcoma in the Right Ventricle
At a Glance
Category
Detail
Condition
Metastatic Ewing Sarcoma
Key Mechanisms
Stereotactic arrhythmia radioablation (STAR) principles applied to cardiac tumors.
Target Population
Patients with unresectable cardiac metastases.
Care Setting
Multidisciplinary oncology and radiotherapy department.
Key Highlights
Application of STAR-inspired 25 Gy single-fraction cardiac radioablation.
Durable control of right-ventricular metastasis with no observed cardiac toxicity.
Patient remained free of cardiac symptoms and disease progression at 31 months post-treatment.
Guideline-Based Recommendations
Diagnosis
Use multimodal imaging for characterization of cardiac lesions.
Management
Consider STAR-inspired SBRT for unresectable cardiac tumors.
Monitoring & Follow-up
Regular cardiac assessments including ECG and imaging to monitor for functional abnormalities.
Risks
Potential for treatment-related functional cardiac impairment.
Patient & Prescribing Data
26-year-old male with a history of limb Ewing sarcoma and cardiac metastasis.
Single-fraction SBRT delivered safely with effective target coverage.
Clinical Best Practices
Utilize frameless stereotactic body radiotherapy for cardiac targets.
Implement respiratory-gated CT simulation to minimize motion uncertainties.
